Articles dans des revues avec comité de lecture (192)
137.
Demanet, C., Brissinck, J., Leo, O., Moser, M., & Thielemans, K. (1994). Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma. Cancer research, 54(11), 2973-2978.138.
Donckier De Donceel, V., Flament, V., Gérard, C., Abramowicz, D., Vandenabeele, P., Wissing, K. M., Delvaux, A., Fiers, W., Leo, O., & Velu, T. (1994). Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10. Transplantation, 57(10), 1436-1439. doi:10.1097/00007890-199405000-00005139.
Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., & Moser, M. (1994). Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. European Journal of Immunology, 24(3), 605-610. doi:10.1002/eji.1830240317140.
Dubois, P., Andris, F., Shapiro, R. A., Gilliland, L. K., Kaufman, M., Urbain, J., Ledbetter, J. A., & Leo, O. (1994). T cell long-term hyporesponsiveness follows antigen receptor engagement and results from defective signal transduction. European Journal of Immunology, 24(2), 348-354. doi:10.1002/eji.1830240212141.
Flamand, V., Lespagnard, L., Thielemans, K., Leo, O., Urbain, J., & Moser, M. (1993). Enhancement of a spontaneous immune response against a B-cell lymphoma by dendritic cells leads to protection against the tumor. Annals of the New York Academy of Sciences, 690, 382-384. doi:10.1111/j.1749-6632.1993.tb44038.x142.
Durez, P., Abramowicz, D., Gérard, C., Van Mechelen, M., Amraoui, Z., Dubois, C., Leo, O., Velu, T., & Goldman, M. (1993). In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. The Journal of experimental medicine, 177(2), 551-555. doi:10.1084/jem.177.2.551143.
Velu, T., Durez, P., Van Mechelen, M., Gérard, C., Abramowicz, D., Moser, M., Leo, O., & Goldman, M. (1993). In vivo induction of IL-10 by anti-CD3 monoclonal antibody in mice. Transplantation proceedings, 25(1 Pt 1), 568-569.144.
Brissinck, J., Demanet, C., Moser, M., Leo, O., & Thielemans, K. (1993). Bispecific antibodies in lymphoma. International reviews of immunology, 10(2-3), 187-194. doi:10.3109/08830189309061695145.
Sornasse, T., Flamand, V., De Becker, G., Thielemans, K., Urbain, J., Leo, O., & Moser, M. (1993). Loading of dendritic cells with antigen in vitro or in vivo by immunotargeting can replace the need for adjuvant. Advances in experimental medicine and biology, 329, 299-303. doi:10.1007/978-1-4615-2930-9_50146.
Flamand, V., Sornasse, T., Thielemans, K. M., Demanet, C., Leo, O., Urbain, J., & Moser, M. (1993). Vaccination with tumor antigen-pulsed dendritic cells induces in vivo resistance to a B cell lymphoma. Advances in experimental medicine and biology, 329, 611-616.147.
Urbain, J., Brait, M., De Wit, D., Ismaili, J., Leo, O., Ryelandt, M., Tassignon, J., Vansanten, G., Van Acker, A., & Willems, F. (1992). B cell subsets, idiotype selection: positive selection for some B lymphocytes? International reviews of immunology, 8(2-3), 259-267.